Cargando…
Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective
BACKGROUND: Clinical trials in China have demonstrated that ranibizumab can improve the clinical outcomes of branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO). However, no economic evaluation of ranibizumab has been conducted among Chinese patient population. METHODS: To...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142632/ https://www.ncbi.nlm.nih.gov/pubmed/34024275 http://dx.doi.org/10.1186/s12886-021-01997-1 |